Daiichi Sankyo Uses Ranbaxy For Entrée Into Mexico Market
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo plans to use its ownership of India's Ranbaxy Laboratories to sell the Japanese company's drugs in Mexico